ALB and glioblastoma: In this setup, the albumin NPs can target the GBM cells and tumor vessel endothelial cells to regulate the TME, while the disulfiram/copper complex induced ICD to promote antigen presentation and regorafenib repolarized the M2 macrophages to assume the M1 phenotype (132).